National Asset Management, Inc. Mustang Bio, Inc. Transaction History

National Asset Management, Inc.

$4.29 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 21, 2023	SELL	$0.32 - $0.52 $2,358 - $3,832	-7,371 Reduced 3.66%	194,226 $75,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $0.76 $8,753 - $14,462	-19,029 Reduced 8.63%	201,597 $95,000
Q2 2022 Aug 12, 2022	SELL	$0.58 - $1.13 $52,374 - $102,038	-90,300 Reduced 29.04%	220,626 $130,000
Q1 2022 May 02, 2022	BUY	$0.73 - $1.81 $31,455 - $77,992	43,090 Added 16.09%	310,926 $315,000
Q4 2021 Jan 28, 2022	BUY	$1.66 - $2.64 $24,171 - $38,441	14,561 Added 5.75%	267,836 $445,000

Q3 2021 Nov 16, 2021	BUY	$2.58 - $3.36 $44,118 - $57,456	17,100 Added 7.24%	253,275 $682,000
Q2 2021 Aug 10, 2021	BUY	$2.7 - $3.81 $16,605 - $23,431	6,150 Added 2.67%	236,175 $785,000
Q1 2021 May 13, 2021	BUY	$3.02 - $5.16 $105,319 - $179,949	34,874 Added 17.87%	230,025 $764,000
Q4 2020 Feb 04, 2021	BUY	$2.66 - $4.18 $55,397 - $87,052	20,826 Added 11.95%	195,151 $739,000
Q3 2020 Nov 09, 2020	BUY	$3.01 - $3.88 $13,397 - $17,269	4,451 Added 2.62%	174,325 $550,000
Q2 2020 Jul 31, 2020	BUY	$2.33 - $4.6 $1,677 - $3,311	720 Added 0.43%	169,874 $541,000
Q1 2020 May 06, 2020	BUY	$1.91 - $4.52 $13,666 - $32,340	7,155 Added 4.42%	169,154 $454,000
Q4 2019 Feb 10, 2020	BUY	$2.57 - $4.08 $100,165 - $159,018	38,975 Added 31.68%	161,999 $661,000
Q3 2019 Nov 12, 2019	BUY	$2.74 - $4.65 $41,511 - $70,447	15,150 Added 14.04%	123,024 $402,000
Q2 2019 Aug 05, 2019	BUY	$2.66 - $6.28 $67,960 - $160,447	25,549 Added 31.03%	107,874 $397,000
Q4 2018 Feb 08, 2019	BUY	$2.3 - $5.78 $22,310 - $56,066	9,700 Added 13.36%	82,325 $243,000
Q3 2018 Nov 08, 2018	BUY	$5.71 - $7.58 $8,565 - $11,370	1,500 Added 2.11%	72,625 $433,000
Q2 2018 Oct 05, 2018	BUY	$6.68 - $11.0 $5,678 - $9,350	850 Added 1.21%	71,125 $490,000
Q1 2018 May 15, 2018	SELL	$10.14 - $12.38 $39,039 - $47,663	-3,850 Reduced 5.19%	70,275 $769,000
Q4 2017 Feb 15, 2018	BUY	$8.75 - $11.99 $274,102 - $375,598	31,326 Added 73.19%	74,125 $889,000
Q3 2017 Nov 13, 2017	BUY	$9.8 - $13.1 $419,430 - $560,666	42,799	42,799 $507,000

Others Institutions Holding MBIO

# of Institutions

Shares Held

415K

Call Options Held

Put Options Held

View Full List

About MUSTANG BIO, INC.

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $46.3M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

More about MBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Account